Proteome Sciences PLC
LSE:PRM

Watchlist Manager
Proteome Sciences PLC Logo
Proteome Sciences PLC
LSE:PRM
Watchlist
Price: 2.85 GBX 14% Market Closed
Market Cap: 8.4m GBX
Section:
 

Relative Value

PRM doesn't have a meaningful market cap.

The Relative Value of one PRM stock under the Base Case scenario is hidden GBX. Compared to the current market price of 2.85 GBX, Proteome Sciences PLC is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PRM Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

1.9
P/S
P/S
Price to Sales
1.9
vs History
98
vs Industry
55
Median 3Y
2
Median 5Y
2.2
Industry
4
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
35
Median 3Y
-2.2
Median 5Y
11.1
Industry
31.9
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
48
Median 3Y
-5.2
Median 5Y
5.7
Industry
19.6
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
28
Median 3Y
-4.4
Median 5Y
7.8
Industry
26.9
More Details
Negative
P/B
P/B
Price to Book Value
N/A
vs History
vs Industry
Median 3Y
-2
Median 5Y
-4.2
Industry
2.8
More Details
5
EV/S
EV/S
Enterprise Value to Sales
5
vs History
42
vs Industry
30
Median 3Y
4.2
Median 5Y
4.2
Industry
4
More Details
28.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
28.9
vs History
17
vs Industry
2
Median 3Y
15
Median 5Y
9.1
Industry
8.9
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
38
Median 3Y
-7.4
Median 5Y
12.2
Industry
18.9
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
39
Median 3Y
-6
Median 5Y
12.9
Industry
24.1
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
44
Median 3Y
-11.5
Median 5Y
10.2
Industry
20.3
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
34
Median 3Y
-10
Median 5Y
12
Industry
26.9
More Details
3.3
EV/IC
EV/IC
Enterprise Value to IC
3.3
vs History
65
vs Industry
31
Median 3Y
2.8
Median 5Y
2.9
Industry
2.3
More Details

Multiples Across Competitors

PRM Competitors Multiples
Proteome Sciences PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Proteome Sciences PLC
LSE:PRM
8.4m GBP 1.9 -2.5 -15.7 -10
US
PerkinElmer Inc
LSE:0KHE
1.1T USD 382.2 4 527.2 1 327.9 2 667.7
US
Thermo Fisher Scientific Inc
NYSE:TMO
223.7B USD 5.1 34.1 24.2 31.3
US
Danaher Corp
NYSE:DHR
162.7B USD 6.7 46.5 24.9 37.7
CH
Lonza Group AG
SIX:LONN
36.9B CHF 5.2 50.4 38.4 38.4
US
Agilent Technologies Inc
NYSE:A
39.1B USD 5.6 30 23.2 27.7
US
IQVIA Holdings Inc
NYSE:IQV
38.4B USD 2.4 29.9 14.5 21.8
CN
WuXi AppTec Co Ltd
SSE:603259
259.2B CNY 5.8 17.3 19.7 19.7
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW 8.4 29 16.9 22.5
US
Mettler-Toledo International Inc
NYSE:MTD
28.8B USD 7.3 34.5 24.9 27.6
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.3B EUR 6.9 76.7 27.3 44.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
Proteome Sciences PLC
LSE:PRM
Average EV/EBITDA: 154.2
Negative Multiple: -15.7 		N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 327.9
5%
265.6
US
Thermo Fisher Scientific Inc
NYSE:TMO
24.2
6%
4
US
Danaher Corp
NYSE:DHR
24.9
5%
5
CH
Lonza Group AG
SIX:LONN
38.4
18%
2.1
US
Agilent Technologies Inc
NYSE:A
23.2
13%
1.8
US
IQVIA Holdings Inc
NYSE:IQV
14.5
8%
1.8
CN
WuXi AppTec Co Ltd
SSE:603259
19.7
30%
0.7
KR
Samsung Biologics Co Ltd
KRX:207940
16.9
20%
0.8
US
Mettler-Toledo International Inc
NYSE:MTD
24.9
4%
6.2
FR
Sartorius Stedim Biotech SA
PAR:DIM
27.3
19%
1.4

See Also

Summary
PRM intrinsic value, competitors valuation, and company profile.
DCF Valuation
PRM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PRM stock valuation using valuation multiples.
Wall Street Estimates
PRM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PRM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 306,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.